Telo Genomics Corp. (TELO.V)

0.1500 0.0000 (0.00%) At close: 09:30AM EDT

Telo Genomics Corp.

MaRS Centre
South Tower Suite 200 101 College Street
Toronto, ON M5G 1L7
Canada
416-673-8487
https://www.telodx.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Sabine Mai Ph.D.	Founder, Interim CEO, Chair of the Clinical & Scientific Advisory Board and Director	30k	N/A	N/A
Dr. Sherif Louis MSc, Ph.D., PMP	President & CTO	231.51k	N/A	N/A
Mr. Christopher Ross CPA, CGA	Chief Financial Officer	67.5k	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides TeloView-SMM application; TeloView, an analysis software platform for prediction of genomic instability. It has a collaboration agreement with the Mayo Clinic to validate its SMM tests for multiple myeloma. Telo Genomics Corp. is headquartered in Toronto, Canada.

Corporate Governance

Telo Genomics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.